Effect of tens on pain in relation to central sensitization in patients with osteoarthritis of the knee: study protocol of a randomized controlled trial

David Beckwée, Willem De Hertogh, Pierre Lievens, Ivan Bautmans, Peter Vaes, David Beckwée, Willem De Hertogh, Pierre Lievens, Ivan Bautmans, Peter Vaes

Abstract

Background: Central sensitization has recently been documented in patients with knee osteoarthritis (OAk). So far, the presence of central sensitization has not been considered as a confounding factor in studies assessing the pain inhibitory effect of tens on osteoarthritis of the knee. The purpose of this study is to explore the pain inhibitory effect of burst tens in OAk patients and to explore the prognostic value of central sensitization on the pain inhibitory effect of tens in OAk patients.

Methods: Patients with knee pain due to OAk will be recruited through advertisements in local media. Temporal summation, before and after a heterotopic noxious conditioning stimulation, will be measured. In addition, pain on a numeric rating score, WOMAC subscores for pain and function and global perceived effect will be assessed. Patients will be randomly allocated to one of two treatment groups (tens, sham tens). Follow-up measurements will be scheduled after a period of 6 and 12 weeks.

Discussion: Tens influences pain through the electrical stimulation of low-threshold A-beta cutaneous fibers. The responsiveness of central pain-signaling neurons of centrally sensitized OAk patients may be augmented to the input of these electrical stimuli. This would encompass an adverse therapy effect of tens. To increase treatment effectiveness it might be interesting to identify a subgroup of symptomatic OAk patients, i.e., non-sensitized patients, who are likely to benefit from burst tens.

Trial registration: ClinicalTrials.gov: NCT01390285.

References

    1. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58:26–35. doi: 10.1002/art.23176.
    1. Mannoni A, Briganti MP, Di Bari M, Ferrucci L, Costanzo S, Serni U, Masotti G, Marchionni N. Epidemiological profile of symptomatic osteoarthritis in older adults: a population based study in Dicomano, Italy. Ann Rheum Dis. 2003;62:576–578. doi: 10.1136/ard.62.6.576.
    1. Dawson J, Linsell L, Zondervan K, Rose P, Randall T, Carr A, Fitzpatrick R. Epidemiology of hip and knee pain and its impact on overall health status in older adults. Rheumatology. 2004;43:497–504. doi: 10.1093/rheumatology/keh086.
    1. Reginster JY. The prevalence and burden of arthritis. Rheumatology. 2002;41(Supp 1):3–6.
    1. Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum. 2009;60:3546–3553. doi: 10.1002/art.24984.
    1. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage. 2007;15:981–1000. doi: 10.1016/j.joca.2007.06.014.
    1. Chesterton LS, van der Windt DA, Sim J, Lewis M, Mallen CD, Mason EE, Warlow C, Vohora K, Hay EM. Transcutaneous electrical nerve stimulation for the management of tennis elbow: a pragmatic randomized controlled trial: the TATE trial (ISRCTN 87141084) BMC Musculoskelet Disord. 2009;10:156. doi: 10.1186/1471-2474-10-156.
    1. Chesterton LS, Barlas P, Foster NE, Lundeberg T, Wright CC, Baxter GD. Sensory stimulation (TENS): effects of parameter manipulation on mechanical pain thresholds in healthy human subjects. Pain. 2002;99:253–262. doi: 10.1016/S0304-3959(02)00118-5.
    1. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150(699):971–979. doi: 10.1126/science.150.3699.971.
    1. Royal Australian College Of General Practitioners T. Guideline for the nonsurgical management of hip and knee osteoarthritis. South Melbourne; 2009.
    1. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16:137–162. doi: 10.1016/j.joca.2007.12.013.
    1. Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for knee pain. Phys Ther. 2001;81:1675–1700.
    1. Rutjes AW, Nuesch E, Sterchi R, Kalichman L, Hendriks E, Osiri M, Brosseau L, Reichenbach S, Juni P. Transcutaneous electrostimulation for osteoarthritis of the knee. Cochrane Database Syst Rev. 2009. p. CD002823.
    1. Meyer R, Campbell J, Raja S. In: Textbook of Pain fifth edn. Wall PD, Melzack R, editor. Churchill Livingstone, Edinburgh; 1995. Peripheral neural mechanisms of nociception; pp. 13–44. (Series Editor)
    1. Nijs J, Van Oosterwijck J, De Hertogh W. Rehabilitation of chronic whiplash: treatment of cervical dysfunctions or chronic pain syndrome? Clin Rheumatol. 2009;28:243–251. doi: 10.1007/s10067-008-1083-x.
    1. Arendt-Nielsen L, Nie H, Laursen MB, Laursen BS, Madeleine P, Simonsen OH, Graven-Nielsen T. Sensitization in patients with painful knee osteoarthritis. Pain. 2010;149:573–581. doi: 10.1016/j.pain.2010.04.003.
    1. Farrell MJ, Gibson SJ, McMeeken JM, Helme RD. Increased movement pain in osteoarthritis of the hands is associated with A beta-mediated cutaneous mechanical sensitivity. J Pain. 2000;1:229–242. doi: 10.1054/jpai.2000.8279.
    1. Schaible H-G. Spinal mechanisms contributing to joint pain. Novartis Found Symp. 2004;260:4–22; discussion 22.
    1. Martindale JC, Wilson AW, Reeve AJ, Chessell IP, Headley PM. Chronic secondary hypersensitivity of dorsal horn neurones following inflammation of the knee joint. Pain. 2007;133:79–86. doi: 10.1016/j.pain.2007.03.006.
    1. Imamura M, Imamura ST, Kaziyama HHS, Targino RA, Hsing WT, de Souza LPM, Cutait MM, Fregni F, Camanho GL. Impact of nervous system hyperalgesia on pain, disability, and quality of life in patients with knee osteoarthritis: a controlled analysis. Arthritis Rheum. 2008;59:1424–1431. doi: 10.1002/art.24120.
    1. Cathcart S, Winefield AH, Rolan P, Lushington K. Reliability of temporal summation and diffuse noxious inhibitory control. Pain Res Manag. 2009;14:433–438.
    1. Staud R, Craggs JG, Robinson ME, Perlstein WM, Price DD. Brain activity related to temporal summation of C-fiber evoked pain. Pain. 2007;129:130–142. doi: 10.1016/j.pain.2006.10.010.
    1. Sarlani E, Grace EG, Reynolds MA, Greenspan JD. Sex differences in temporal summation of pain and aftersensations following repetitive noxious mechanical stimulation. Pain. 2004;109:115–123. doi: 10.1016/j.pain.2004.01.019.
    1. Le Bars D. The whole body receptive field of dorsal horn multireceptive neurones. Brain Res Brain Res Rev. 2002;40:29–44.
    1. van Wijk G, Veldhuijzen DS. Perspective on diffuse noxious inhibitory controls as a model of endogenous pain modulation in clinical pain syndromes. J Pain. 2010;11:408–419. doi: 10.1016/j.jpain.2009.10.009.
    1. Nijs J, Van Houdenhove B, Oostendorp RAB. Recognition of central sensitization in patients with musculoskeletal pain: Application of pain neurophysiology in manual therapy practice. Man Ther. 2010;15:135–141. doi: 10.1016/j.math.2009.12.001.
    1. Curatolo M, Petersen-Felix S, Arendt-Nielsen L, Giani C, Zbinden AM, Radanov BP. Central hypersensitivity in chronic pain after whiplash injury. Clin J Pain. 2001;17:306–315. doi: 10.1097/00002508-200112000-00004.
    1. Altman RD. The classification of osteoarthritis. J Rheumatol Suppl. 1995;43:42–43.
    1. Bannuru RR, Natov NS, Dasi UR, Schmid CH, McAlindon TE. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis--meta-analysis. Osteoarthritis and Cartilage. 2011;19:611–619. doi: 10.1016/j.joca.2010.09.014.
    1. Law PPW, Cheing GLY. Optimal stimulation frequency of transcutaneous electrical nerve stimulation on people with knee osteoarthritis. J Rehabil Med. 2004;36:220–225. doi: 10.1080/16501970410029834.
    1. Kirkwood BR, Sterne JAC. Essential Medical Statistics. 2. Victoria 3053: Blackwell Publishing company; 2003.
    1. Bellamy N. Osteoarthritis clinical trials: candidate variables and clinimetric properties. J Rheumatol. 1997;24:768–778.
    1. Kadetoff D, Kosek E. The effects of static muscular contraction on blood pressure, heart rate, pain ratings and pressure pain thresholds in healthy individuals and patients with fibromyalgia. Eur J Pain. 2007;11:39–47. doi: 10.1016/j.ejpain.2005.12.013.
    1. Rakel B, Cooper N, Adams HJ, Messer BR, Frey Law LA, Dannen DR, Miller CA, Polehna AC, Ruggle RC, Vance CG, Walsh DM, Sluka KA. A new transient sham TENS device allows for investigator blinding while delivering a true placebo treatment. J Pain. 2010;11:230–238. doi: 10.1016/j.jpain.2009.07.007.
    1. Crossley KM, Bennell KL, Cowan SM, Green S. Analysis of outcome measures for persons with patellofemoral pain: which are reliable and valid? Arch Phys Med Rehabil. 2004;85:815–822. doi: 10.1016/S0003-9993(03)00613-0.
    1. Hoving JL, Koes BW, de Vet HCW, van der Windt DAWM, Assendelft WJJ, van Mameren H, Deville WLJM, Pool JJM, Scholten RJPM, Bouter LM. Manual therapy, physical therapy, or continued care by a general practitioner for patients with neck pain. A randomized, controlled trial. Ann Intern Med. 2002;136:713–722.
    1. De Hertogh W, Vaes P, Devroey D, Louis P, Carpay H, Truijen S, Duquet W, Oostendorp R. Preliminary results, methodological considerations and recruitment difficulties of a randomised clinical trial comparing two treatment regimens for patients with headache and neck pain. BMC Musculoskelet Disord. 2009;10:115. doi: 10.1186/1471-2474-10-115.
    1. De Hertogh WJ, Vaes PH, Devroey D, Truijen S, Duquet W, Oostendorp R. Management of headache disorders: design of a randomised clinical trial screening for prognostic patient characteristics. BMC Musculoskelet Disord. 2007;8:38. doi: 10.1186/1471-2474-8-38.
    1. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. Int J Surg. 2011;9:672–677. doi: 10.1016/j.ijsu.2011.09.004.
    1. Senn S. Testing for baseline balance in clinical trials. Statistics in Medicine. 1994;13:1715–1726. doi: 10.1002/sim.4780131703.
    1. DeSantana JM, Walsh DM, Vance C, Rakel BA, Sluka KA. Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain. Curr Rheumatol Rep. 2008;10:492–499. doi: 10.1007/s11926-008-0080-z.
    1. DeSantana JM, Da Silva LFS, De Resende MA, Sluka KA. Transcutaneous electrical nerve stimulation at both high and low frequencies activates ventrolateral periaqueductal grey to decrease mechanical hyperalgesia in arthritic rats. Neuroscience. 2009;163:1233–1241. doi: 10.1016/j.neuroscience.2009.06.056.
    1. Cheing GLY, Tsui AYY, Lo SK, Hui-Chan CWY. Optimal stimulation duration of tens in the management of osteoarthritic knee pain. J Rehabil Med. 2003;35:62–68. doi: 10.1080/16501970306116.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe